| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| EPIC Bpifrance | Member of 10% owner group | 6-8, BOULEVARD HAUSSMANN, PARIS, FRANCE | /s/ Sophie Paquin, Director of Legal Affairs, EPIC Bpifrance | 20 May 2025 | 0001731121 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | DBVT | Ordinary Shares | 10.7M | 27 Mar 2025 | By Bpifrance Participations S.A. | F1 | |||||
| holding | DBVT | Ordinary Shares | 226K | 27 Mar 2025 | By Innobio FPCI | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | DBVT | Warrants (right to buy) | 27 Mar 2025 | Ordinary Shares | 6.56M | By Bpifrance Participations S.A. | F1, F3 |
| Id | Content |
|---|---|
| F1 | Bpifrance Participations S.A. ("Bpifrance Participations") directly owns the reported shares. Bpifrance Participations is a subsidiary owned at 99.99% by Bpifrance S.A. ("Bpifrance"). Bpifrance is jointly owned by Caisse des Depots et Consignations ("CDC") at 49.2% and EPIC Bpifrance ("EPIC") at 49.2%. CDC and EPIC jointly control Bpifrance. |
| F2 | Innobio FPCI ("Innobio") directly owns the reported shares. Innobio is a fund managed by Bpifrance Investissement S.A.S. ("Bpifrance Investissement"), a subsidiary owned at 100% by Bpifrance Participations. |
| F3 | The exercise of one warrant will give the right to subscribe to 1.75 ordinary shares at a price of (euro)1.5939 per warrant. |